Protease inhibitors-based therapy induces acquired spherocytic-like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients.
Lupo F, Russo R, Iolascon A, Ieluzzi D, Siciliano A, Toniutto P, Matté A, Piovesan S, Raffetti E, Turrini F, Dissegna D, Donato F, Alberti A, Zuliani V, Fattovich G, De Franceschi L.
Lupo F, et al. Among authors: fattovich g.
Liver Int. 2016 Jan;36(1):49-58. doi: 10.1111/liv.12900. Epub 2015 Jul 14.
Liver Int. 2016.
PMID: 26104535